Skeletal myopathy was found in almost all-transgenic mice carrying the human prototype c-Ha-ras gene (rasH2 mouse). Microscopically, variation of the muscle fiber size, centrally placed nuclei, regenerating fibers, and interstitial fibrosis were evident; hyalinization and necrosis were sometimes observed in the skeletal muscle (femoralis and pectoralis) of the rasH2 mice. Inflammatory changes in the skeletal muscle or abnormality of adjacent peripheral nerve were not observed. The features were essentially similar to those of muscular dystrophy. Although the severity was relatively mild compared to 34-week-old rasH2 mice, the skeletal myopathy was also observed in younger male (10 weeks of age) rasH2 mice. In nontransgenic littermates, skeletal myopathy was not observed. The mRNA of human c-Ha-ras product was detected in femoral muscle from the rasH2 mice by RT-PCR. In conclusion, these data suggest that skeletal myopathy is occurring in almost all rasH2 mice. Integration of c-Ha-ras gene is thought to be crucial to pathogenesis of skeletal myopathy in the rasH2 mice. Further characterization of the muscular lesion and its pathogenesis are needed to explore the possibility of rasH2 mouse becoming a new model for muscular dystrophy.
INTRODUCTION
Muscular dystrophies are known as a group of inherited disorders characterized by progressive muscle wasting and weakness in humans. The one unifying feature of the dystrophies is regarded as their muscle histological findings, with variations in fiber size, fiber necrosis, invasion by macrophages, and ultimately, replacement by fat and connective tissue (8) . The genes and the protein products have been identified for most types of dystrophy (12) . Duchenne muscular dystrophy is characterized by the absence of the protein dystrophin in skeletal muscles (11) . The gene locus of human dystrophin has been identified as Xp21 (10) . Inherited muscular dystrophies have been identified also in animals (4, 6, 18) . Several mouse mutants exhibit muscular dystrophy (3, 17, 33) . The 129ReJ strain (18) , the WK/ReJ strain (3) and C57BL/6J-dy strain (33) indicate the autosomal recessive primary myopathy. The X-chromosome-linked muscular dystrophy (mdx) was identified in the C57BL/10ScSn colony (3) . Dystrophin has not been identified in mdx (11) . The mdx has been much focused in the past 2 decades, because of its genetic equivalent of Duchenne type in humans. These mouse models have been played a pivotal role for elucidating pathogenesis of muscular dystrophy. However, the cellular mechanisms responsible for the progressive skeletal muscle degeneration that characterizes the disease are still debated.
Establishment of new animal model brings new clues to explore the pathogenesis of the disease. Here we report the new mouse with primary skeletal myopathy. The transgenic mouse carrying the human prototype c-Ha-ras gene (CB6F1-Tg Hras2 mice (rasH2 mouse) ) was established by Saitoh et al (26) . Recently, this transgenic mouse is intended to be an alternative model for 2-year carcinogenicity studies (24, 35) . We have found skeletal myopathy in almost all rasH2 mice in 26-week carcinogenicity studies. The ras gene has been implicated in controlling cell proliferation, differentiation, and apoptosis (2) . In addition, some studies have suggested that activated H-ras oncogenes can prevent the differentiation of cultured lines of skeletal myoblasts (23, 26, 32) . Abnormalities in proliferation and differentiation of the muscular dystrophy are a controversial aspect. Therefore it is of considerable interest that rasH2 mice integrated c-Ha-ras gene exhibit histological lesions corresponding to muscular dystrophy.
This study provides, for the first time, histopathological features of the skeletal myopathy in rasH2 mice.
MATERIALS AND METHODS rasH2 Mice
C57BL/6J males carrying the human hybrid c-Ha-ras DNA were crossed with BALB/cByJ females. The F1 mice carrying the human c-Ha-ras gene (heterozygous for the transgene) are the rasH2 mice. Four or 5 copies of the transgene were integrated into the genome of this mouse in a tandem array (20, 34) , and the structure of the integrated transgene in rasH2 mice was described in detail by Saitoh et al (26) . Briefly, it was constructed by ligation of 2 parts from human activated c-Ha-ras genes with single point mutation at the 12th or the 61st codon. It encodes the prototype human c-Ha-ras product (p21), and includes its own promoter region originating from the human activated c-Ha-ras gene. This hybrid human c-Haras DNA did not include the 12th or the 61st codon mutation; however, it still had a point mutation in the last intron that caused a high gene expression (5) . 501 0192-6233/02$3.00+$0.00 502 TSUCHIYA ET AL TOXICOLOGIC PATHOLOGY
Study Design and Husbandry
Twenty-six-week carcinogenicity studies were performed according to the standard protocol proposed by the International Life Sciences Institute (ILSI) Health and Environmental Sciences Institute (24) . A total of 53 male and 43 female rasH2 mice and 53 males and 45 females nontransgenic littermates (non-Tg mice) (Central Institute of Experimental Animals, Kawasaki, Japan) were housed 3 or 5 to a polycarbonate cage with hardwood chips and maintained in an environmentcontrolled animal room with a 12/12-hour light/dark cycle. Food (CRF-1, Oriental Yeast Co, Tokyo, Japan) and tap water were provided ad libitum. These animals were used as controls in four 26-week carcinogenicity studies and a short-term study. At the termination of each study, mice were sacrificed under diethylether anesthesia. All mice used in these studies were treated according to the rules described in the Standards Relating to the Care and Management of Experiment Animals (1980, Prime Minister's Office, Japan).
Necropsy and Histopathology
Among the four 26-week carcinogenicity studies, 50 males and 43 females of rasH2 mice and 50 males and 45 females of non-Tg mice were sacrificed at 34 weeks of age. An additional 3 males of rasH2 and non-Tg mice were sacrificed at 10 weeks of age in a short-term study. At necropsy, the femoral and pectoral muscle, heart, tongue, and esophagus from all of the animals were fixed in 10% neutral bufferedformalin and processed routinely for hematoxylin and eosin stain, and examined microscopically. Azan stain was conducted on representative slides to confirm fibrosis.
RT-PCR for p21 mRNA
Expression of trans gene-product (p21) mRNA was assessed by RT-PCR. Femoral muscle and liver from rasH2 and non-Tg mice were analyzed. Total RNA was purified by the modified acid guanidinium isothiocyanate-phenolchloroform method using ISOGEN (Nippon Gene, Tokyo, Japan) according to manufacturer's instructions, and digested with DNase 1 (Boehringer Mannheim, Mannheim, Germany), followed by cDNA synthesis by reverse transcription using Superscript reverse-transcriptase (Gibco BRL). PCR amplification was performed for 35 cycles with 94 • C denaturation for 45 minutes, annealing for 30 seconds with 55 • C, 70 • C extension for 1 minute and 70 • C end-synthesis for 10 minutes. The primers (sense, 5 -GACGGAATAT AAGCTGGTGG-3 , anti-sense, 5 -GGTCGTATTC GTCCACAAA-3 ) amplified c-Ha-ras Portion  No of animals  50  50  3  3  43 cDNA-specific 99 bp sequence. A 1 2 volume of PCR sample was separated on a 1% agarose gel and visualized by ethidium bromide staining. The cell line from human colorectal cancerexpressing H-ras gene (30) , Lovo (Dainippon Pharmaceutical Co Ltd, Osaka, Japan), was used as a positive control.
RESULTS

Clinical Observation
No abnormalities suggesting muscle weakness or motor function abnormality or abnormal gait were found in rasH2 mice from all of the studies. Bodyweights of rasH2 mice in 26- week studies were about 80-100% of non-Tg mice at 26-weeks, in accordance with the results of the previous reports (14, 20, 21, 28) .
Histopathology Table 1 summarizes the incidence of myopathy in the rasH2 and non-Tg mice from all of the studies. Myopathy was found in both of skeletal muscle in 10-or 34-week-old rasH2 mice. Regardless of the sex, skeletal myopathy was detected in all rasH2 mice by the examinations of femoral and pectoral muscle, yet in heart, tongue and esophagus, no abnormality was found in rasH2 mice. In the non-Tg mice, myopathy was not observed. Incidences of myopathy in femoral and pectoral muscles of the rasH2 mice in each study are shown in Table 2 . We examined femoral and pectoral muscle as the representative skeletal muscles. The variations of muscle fiber size due to hypertrophy of some and atrophy of the others were evident in the transverse section of muscle fibers ( Figure 1B) . Hyaline degeneration of muscle fibers was noted ( Figure 1C ). These degenerative changes were frequently accompanied by cellular infiltration (granulocytes and macrophages), suggesting reaction to degeneration or phagocytosis of Vol. 30 degenerative fibers ( Figure 1E ). Proliferation and long chain of the nuclei and small sized muscular fibers with central nuclei, suggesting muscular regeneration were also seen ( Figure 1C-D) . Slight increase of interstitial collagen fibers was confirmed by Azan stain in 34-week-old rasH2 mice ( Figure 2 ). Abnormality of adjacent peripheral nerve was not observed in the rasH2 mice. Histological findings in the pectoral muscle from rasH2 mice were basically same as femoral muscle. These microscopic features were basically similar between 10-and 34-week-old rasH2 mice. However, the degrees of skeletal myopathy in 34-week-old rasH2 mice were slightly severe than those of 10-week-old mice.
The mRNA Expression of the Transgene
Expression of the transgenic human prototype c-Haras was assessed by RT-PCR. Transgene-specific primers amplified a c-Ha-ras cDNA-specific 99bp sequence in both femoral muscle and liver from rasH2 mice but not in non-Tg mice (Figure 3 ).
DISCUSSION
The lesions in the skeletal muscle from the rasH2 mice consisted of primary myogenic degeneration. In addition, secondary changes to degenerative muscle fibers and muscle fiber regeneration were observed. These characteristics of muscular lesions in rasH2 mice corresponded to the histological features of muscular dystrophy. There was no inflammatory lymphocytic infiltration around the intact muscle and perivascular area as identified in polymyositis or dermatomyositis. The muscular myopathy was restricted to the rasH2 mice (not observed in non-Tg mice), and its incidence was 100%. It seems that integration of the human c-Ha-ras gene was closely related to the occurrence of this muscular myopathy.
Several mouse models that exhibit muscular dystrophy have been described (3, 17, 33) . Clinical or histological similarities or differences were confirmed between rasH2 and other muscular dystrophy mice. A distinct difference between rasH2 mice and dy/dy mice was recognizedin clinical phenotype. Motor function failure or muscle weakness, based on poor regeneration and fibrous tissue or fatty replacement, has been reported in dy/dy mice (33) . Although in the rasH2 mouse, muscle weakness or motor function failure has not been observed in our 26-week studies. In terms of clinical phenotype, rasH2 mice seem to be similar to mdx mice. The mdx mice also exhibits no obvious muscle weakness until about 12 months of age, resulting from muscle fiber regeneration without extensive fibrous proliferation (3) . Muscle fiber regeneration in response to fiber necrosis is thought to be the pivotal factor to understand the clinical expression of muscular dystrophy (27) . Muscle fiber regeneration was observed in the rasH2 mice, and extensive fibrous or fatty replacements were not the feature of the rasH2 mice skeletal myopathy as same as mdx mice. These findings were thought to attribute to the lack of clinical expression in these ages of rasH2 mice. The severity of muscular myopathy in 10-week-old rasH2 mice was milder than that of 34-week-old rasH2 mice. While in the mdx mice, it is known that muscle fiber necrosis and regeneration is most florid in relatively young animals (30-60 days of age) (1), later 80% of muscle fibers are thought to be replaced by regenerative muscle fibers with centrally placed nuclei by 60 days (27, 33) . It is one of the histological character in mdx mice that muscle fibers with centrally placed nuclei were frequently seen in large groups among the otherwise normal muscular fibers (3, 27) . In rasH2 mice, muscle fibers with centrally placed nuclei were scattered among the muscle fiber. To confirm the chronological process of muscular lesions in the rasH2 mice, younger animals less than 10 weeks old need to be examined.
As to the otherwise skeletal muscle, myocardial involvement was not observed in the rasH2 mice, nor in the dy/dy mice (27) . Myocardial involvement has been found in various types of the human muscular dystrophy (9); however, animal models seldom display cardiac abnormalities. The mdx mice is known to display cardiac abnormalities rarely (7, 29) . Recently, Megeney et al (1999) reported that the mdx: MyoD −/− mice, lacking both MyoD and Dystrophin, display distinct cardiomyopathy. According to their report, progression of skeletal muscle damage is the significant contributing factor leading to development of cardiomyopathy (16) . Additionally, visceral striated muscle fibers from such as tongue and esophagus did not exhibit myopathy in the rasH2 mice, as shown in the result. The lack of tongue involvement was also recognized in the dy/dy mice (31) .
It is undoubted that integration of c-Ha-ras gene is the key factor of the occurrence of skeletal myopathy in the rasH2 mice, however, its pathogenesis is unclear. The transgene was expressed in both femoral muscle and liver of rasH2 mice. These results suggested universal expression of transgene in the rasH2 mice. The transgene expression in affected muscle, demonstrated by RT-PCR, might contribute to pathogenesis of rasH2 myopathy, because the H-ras gene has been reported to inhibit myogenesis in vitro (13, 22, 23, 32) . Other oncogenes such as c-myc and N-ras also inhibit muscle differentiation in vitro, suggesting that growth-promoting factors negatively regulate the myogenic regulatory factors (15, 19, 22) . The myogenic regulatory factors (MRFs: MyoD, Myf-5, myogenin, and MRF4) are known to regulate the specification and the differentiation of the muscle lineage (25) . Konieczny SF et al has reported that H-ras expression down regulate MyoD gene (13) .
Abnormalities in proliferation and differentiation of the muscular dystrophy are a controversial aspect. The rasH2 mice may provide new information on the development of muscular dystrophy-like lesions.
In summary, the present study provides the pathological feature of the skeletal myopathy in rasH2 mice. The histopathological findings observed in the skeletal muscles of rasH2 mice basically corresponded to those of muscular dystrophy in human and animal models. However, the underlying mechanisms of rasH2 skeletal myopathy are unknown. Further characterization studies are needed for utilization of rasH2 mice as a model of muscular dystrophy.
